- Global Pharma News & Resources

CBx Sciences Releases Encapsulated Cannabinoid 'Gems' in Colorado

CBx Sciences Releases Encapsulated Cannabinoid 'Gems' in Colorado Proven Pharmaceutical Formulations and Transmucosal Delivery Method Ensure Consistent High Bioavailability and Rapid Effects

PR Newswire

DENVER, Aug. 14, 2018

DENVER, Aug. 14, 2018 /PRNewswire/ -- CBx Sciences, a CBx Enterprises brand, today announced the availability of its new Gems product line. Based on proven pharmaceutical delivery technology formulated by CBx Sciences Chief Scientist, Noel Palmer, Ph.D., Gems are small, discreet, lightly flavored lozenges that transmucosally deliver doses of potent cannabinoids, terpenes and complementary botanicals.

"Traditional cannabis edibles are subject to first pass metabolism which greatly reduces their efficacy, and makes reliable dosing nearly impossible," explained Palmer. "With a proprietary cannabinoid encapsulation process, and delivery that eliminates first pass metabolism of cannabinoids, Gems delivers a consistent dose that takes effect quickly and lasts."

Gems will initially be available in two formulations designed to complement CBx Sciences' Meditate and Amplify Botanical Vapes. Amplify combines Green Tea extract with the proven energizing effects of Vitamin B12, CBD and THC, while Meditate Botanical blends are a calming combination of Gaba, Melatonin, THC, CBD and CBN.

To find the location with Gems nearest you, visit: Stay tuned for additional CBx Sciences Gems formulations and new products in the coming months.

About CBx Sciences:
CBx Sciences is an international botanical technology company. Founded by a team of seasoned experts, the company is dedicated to advancing the global cannabis industry by creating effective products, formulations and technology platforms that support and replenish the Endocannabinoid System. CBx Sciences holds distribution, licensing and intellectual property agreements with a number of leading cannabis and healthcare brands including Evolab. Learn more at

Supporting Resources:
Follow @CBxSciences on:

Media Inquiries:
Graham Sorkin


View original content:

SOURCE CBx Sciences

Editor Details

Last Updated: 14-Aug-2018